Abstract
The unproven stem cell intervention (SCI) industry is a global health problem. Despite efforts of some nations, the industry continues to flourish. In this paper, we call for a global approach and the establishment of a World Health Organization (WHO) Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. The WHO committee can harmonize national regulations; promote regulatory approaches responsive to unmet patient needs; and formulate an education campaign against misinformation. Fostering an international dialog and developing recommendations that can be adopted by member states would effectively address the global market of unproven SCIs.
Original language | English (US) |
---|---|
Pages (from-to) | 1435-1445 |
Number of pages | 11 |
Journal | Stem Cell Reports |
Volume | 16 |
Issue number | 6 |
DOIs | |
State | Published - Jun 8 2021 |
Keywords
- World Health Organization
- global health
- patient views
- regenerative medicine
- regulations
- unproven stem cell interventions
ASJC Scopus subject areas
- Biochemistry
- Genetics
- Developmental Biology
- Cell Biology